Discover leading companies in Boston's biotech hub sponsoring Biotechnology Researcher positions.
For international professionals in the biotechnology field targeting Boston, securing H-1B sponsorship is paramount. Get Wisa provides data-driven insights into companies with a proven track record of sponsoring Biotechnology Researcher roles in this leading innovation center.
| Feature | Data Point | Trend vs 2025 |
|---|---|---|
| FY2027 Lottery Odds (Overall) | 35.3% | ↓ 27% |
| PWD Processing Time | 3-4 months | → Stable |
| PERM Filing Records (Wisa) | 283,422 | N/A |
| Top Boston Sponsor (Biogen) Filings | [Data not available for specific city] | N/A |
| Total H-1B Filing Records (Wisa) | 323,617 | N/A |
| New Form I-129 Mandatory | April 2026 | N/A |
Analysis of DOL data indicates that while overall H-1B registrations decreased for FY2027, the demand for specialized roles in biotech hubs like Boston remains strong. Companies sponsoring Biotechnology Researchers often offer competitive salaries, placing them in higher wage brackets that benefit from the new lottery system.
When evaluating offers, check the employer's Prevailing Wage Determination (PWD) processing history on Get Wisa. Faster PWDs can indicate a more streamlined internal immigration process, potentially leading to quicker H-1B filings.
The FY2027 H-1B lottery saw a 27% decrease in registrations, resulting in overall selection odds of 35.3%. The introduction of the wage-weighted system significantly boosted chances for higher-paying positions, with Level 4 wages seeing approximately 62% odds, compared to ~15% for Level 1. For Biotechnology Researchers in Boston, this means companies offering salaries in the higher tiers have a distinct advantage.
While PERM processing times average 503 days, the PWD process takes 3-4 months. The mandatory April 2026 update to Form I-129 and expanded social media vetting are also critical factors to monitor for all H-1B applicants this year.
Leading biotech firms in Boston, such as Biogen and Vertex Pharmaceuticals, are consistent sponsors of H-1B visas. For example, Biogen has historically filed thousands of LCA applications, many of which are for specialized research and development roles. Moderna is another significant player in the Boston biotech ecosystem, actively seeking to sponsor talent for critical research positions.
Q: What are the typical wage levels for Biotechnology Researchers in Boston?
A: Wages for Biotechnology Researchers in Boston often fall into Level 3 or Level 4 due to the specialized nature of the work and the high cost of living in the area.
Q: How does the wage-weighted lottery impact Biotechnology Researcher roles?
A: The wage-weighted system significantly favors higher-paying roles. Biotechnology Researcher positions, often qualifying for Level 3 or 4 wages, have considerably better selection odds in the FY2027 lottery.
Q: What is the average PWD processing time for biotech roles in Boston?
A: Prevailing Wage Determination (PWD) processing nationally takes 3-4 months. This timeframe is generally consistent across major tech and biotech hubs like Boston.
Q: Are there specific H-1B filing trends for research roles in Boston?
A: Yes, Boston consistently shows high H-1B filing volumes for research and development roles within its strong biotech and pharmaceutical sectors, indicating sustained demand.
Search thousands of verified H-1B sponsors by company, industry, and location.
Search H-1B Sponsors on Wisa →Wages for Biotechnology Researchers in Boston often fall into Level 3 or Level 4 due to the specialized nature of the work and the high cost of living in the area.
The wage-weighted system significantly favors higher-paying roles. Biotechnology Researcher positions, often qualifying for Level 3 or 4 wages, have considerably better selection odds in the FY2027 lottery.
Prevailing Wage Determination (PWD) processing nationally takes 3-4 months. This timeframe is generally consistent across major tech and biotech hubs like Boston.
Yes, Boston consistently shows high H-1B filing volumes for research and development roles within its strong biotech and pharmaceutical sectors, indicating sustained demand.